Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment Lassau N; Chebil M; Chami L; Bidault S; Girard E; Roche ATarget Oncol 2010[Mar]; 5 (1): 53-8Dynamic contrast-enhanced ultrasonography (DCE-US) is a new functional technique enabling a quantitative assessment of solid tumor perfusion using raw linear data. DCE-US allows the calculation of parameters as slope of wash-in or area under the curve (AUC) representing, respectively, blood flow or blood volume. Reduction in tumor vascularization can easily be detected in responders after 1 or 2 weeks and is correlated with progression-free survival and overall survival in renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). DCE-US is supported by the French National Cancer Institute (INCa), which is currently studying the technique in metastatic breast cancer, melanoma, colon cancer, gastrointestinal stromal tumors and renal cell carcinoma, as well as in primary hepatocellular carcinoma, to establish the optimal perfusion parameters and timing for quantitative anticancer efficacy assessments. Currently 490 patients are included in 20 centers and the preliminary results on 400 patients with 1,096 DCE-US demonstrated that AUC could be a robust parameter to predict response.|*Perfusion Imaging[MESH]|Angiogenesis Inhibitors/*therapeutic use[MESH]|Blood Circulation[MESH]|Carcinoma, Hepatocellular/blood supply/*diagnosis/drug therapy/pathology[MESH]|Carcinoma, Renal Cell/blood supply/*diagnosis/drug therapy/pathology[MESH]|Clinical Trials as Topic[MESH]|Drug Therapy[MESH]|Early Detection of Cancer[MESH]|France[MESH]|Humans[MESH]|Neoplasm Metastasis[MESH]|Neovascularization, Pathologic[MESH]|Prognosis[MESH]|Ultrasonography/instrumentation/*methods[MESH] |